Jame Abraham, MD, FACP Director, Breast Oncology Program Taussig Cancer Institute, Cleveland Clinic Cleveland, Ohio
Bamidele A. Adesunloye, MD, MS Senior Clinical Fellow, Medical Oncology Service, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
Sanjiv S. Agarwala, MD Professor of Medicine, Temple University; Chief, Oncology and Hematology, St. Luke’s Cancer Center, Bethlehem, Pennsylvania
Sairah Ahmed, MD Assistant Professor of Medicine, Division of Cancer Medicine, Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas
Carmen J. Allegra, MD Professor and Chief, Division of Hematology and Oncology, Associate Director for Clinical and Translational Research, Shands/University of Florida Cancer Center, University of Florida, Gainesville, Florida
Lukas C. Amler, PhD Director, Oncology Biomarker Development, Genentech, Inc., South San Francisco, California
Christina M. Annunziata, MD, PhD Investigator, Medical Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
Andrea B. Apolo, MD Assistant Clinical Investigator, Head, Bladder Cancer Research Program, Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
Philip M. Arlen, MD Attending Physician, Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
Anne Berger, MSN, MD Senior Clinician, Pain and Palliative Care Service, National Institute of Health Clinical Center, National Institutes of Health, Bethesda, Maryland
Philippe C. Bishop, MD Vice President, Product Development Oncology, Angiogenesis Franchise Head Genentech, Inc,. South San Francisco, California
Christopher Bowden, MD Vice President, Global Signing Franchise Head, Product Development, Oncology, Genentech, South San Francisco, California
Oscar S. Breathnach, MB, FRCPI Consultant Medical Oncologist, Clinical Investigator, Beaumont Hospital, Connolly Hospital, Royal College of Surgeons, ICORG Dublin, Ireland
Christina Brzezniak, DO Clinical Fellow, Hematology and Oncology, Walter Reed National Military Medical Center, Bethesda, Maryland
Mauricio E. Burotto Pichún, MD Senior Clinical Fellow, Medical Oncology Service, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
Eric G. Bush, MD, MBA, RPh Medical Director, Frederick Memorial Hospital Pain and Palliative Care Service; Medical Director, Hospice of Frederick County; Chairman, Ethics Committee, Frederick Memorial Hospital, Frederick, Maryland
Jon Cardinal, MD Assistant Professor of Surgery, West Virginia University Hospital, Morgantown, West Virginia
George L. Carter, MMS, PA-C Physician Assistant Medical Oncology Service, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
Ellie E. Chan, MD Assistant Professor of Medicine, Division of Hematology and Oncology, University of California, San Francisco, Fresno Medical Education, California
Bruce D. Cheson, MD Professor of Medicine, Head of Hematology; Deputy Chief, Division of Hematology-Oncology, Georgetown University Hospital, Lombardi Comprehensive Cancer Center, Washington, DC
Richard W. Childs, MD Senior Investigator, Hematology Branch, National Heart Blood and Lung Institute, National Institutes of Health, Bethesda, Maryland
Deborah Citrin, MD Investigator, Radiation Oncology Service, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
Barbara A. Conley, MD Associate Director, Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Rockville, Maryland
David P. Cosgrove, MB, BCh Assistant Professor, Department of Medical Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland
Michael Craig, MD Associate Professor of Medicine, Osborn Hematopoietic Malignancy and Transplantation Program, West Virginia University, Morgantown, West Virginia
Aaron Cumpston, PharmD Pharmacy Clinical Specialist, Osborn Hematopoietic Malignancy and Transplantation Program, West Virginia University, Morgantown, West Virginia
Brendan Curley, DO, MPH Fellow, Section of Hematology/Oncology, Mary Babb Randolph Cancer Center, West Virginia University, Morgantown, West Virginia
William L. Dahut, MD Clinical Director, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
Alexandre Buckley de Meritens, MD Senior Fellow Molecular Signaling Section, Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
Suzanne G. Demko, PA-C Clinical Team Leader, Neuro-Oncology, Pediatric Oncology and Rare Tumors Group, Division of Oncology Products 2, Office of Hematology and Oncology Products, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland
Marnie G. Dobbin, MS, RD Clinical Research Dietitian, Clinical Research Center, National Institutes of Health, Bethesda, Maryland
Mark K. Doherty, MB BCh BAO Consultant, University College Hospital Galway, Galway, Ireland
Jennifer M. Duff, MD Fellow, Division of Hematology and Oncology, University of Florida Health Cancer Center, Gainesville, Florida
Austin Duffy, MB, MRCPI Staff Clinican, Gastrointestinal Malignancies Section, Medical Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
Kieron Dunleavy, MD Staff Clinican, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
Daniel E. Elswick, MD Assistant Professor, Director, Psychosocial Oncology Services, Department of Behavioral Medicine and Psychiatry, West Virginia University, Morgantown, West Virginia
Sharon Romano Fitzgerald, MD Fellow, Gynecologic Oncology, Walter Reed National Military Medical Center and Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
Sheryl B. Fleisch, MD Psychosomatic Medicine Fellow, Department of Psychiatry, University of North Carolina, Chapel Hill, North Carolina
Juan C. Gea-Banacloche, MD Staff Clinician, Infectious Diseases, Experimental Transplantation and Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
Thomas J. George, Jr., MD, FACP Associate Professor, Director, Gastrointestinal Oncology Program, Division of Hematology and Oncology, University of Florida Health Cancer Center, Gainesville, Florida
Giuseppe Giaccone, MD, PhD Chief, Medical Oncology Branch; Head, Thoracic Oncology Section, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
Govardhanan Nagaiah, MD Attending, Medical Oncology/Hematology New Mexico Cancer Center, Albuquerque, New Mexico
Ann W. Gramza, MD Medical Oncologist, Endocrine Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
Tim F. Greten, MD Chief, Gastrointestinal Cancer Section, Medical Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
James L. Gulley, MD, PHD, FACP Chief, Medical Oncology Service, Center for Cancer Research, National Cancer Institute, National Institutes of Health Bethesda, Maryland, Formerly of Emory University School of Medicine, And Loma Linda University School of Medicine
Karl E. Haglund, MD, PhD Assistant Clinical Investigator, Radiation Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
Mehdi Hamadani, MD Associate Professor of Medicine, Division of Hematology & Oncology, Medical College of Wisconsin & CIBMTR, Milwaukee, Wisconsin
Chad A. Hamilton, MD, Lt Col, USAF, MC Chief, Gynecologic Oncology Service; Co-Director, DOD Gynecologic Cancer Translational Research Center, Walter Reed National Military Medical Center, Bethesda, Maryland
Garrett M. Hampton, PhD Senior Director, Oncology Biomarker Development, Genentech, Inc., South San Francisco, California
Hannah W. Hazard, MD, FACS Assistant Professor of Surgery, Chief of Surgical Oncology, Assistant Dean for Admissions, West Virginia University School of Medicine, West Virginia
Christopher Ryan Heery, MD Staff Clinician, Laboratory of Tumor Immunology and Biology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
Upendra P. Hegde, MD Associate Professor of Medicine, Associate Director of Cutaneous Melanoma Program, University of Connecticut Health Center, Neag Comprehensive Cancer Center, Farmington, Connecticut
Lee J. Helman, MD Scientific Director for Clinical Research, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
Joleen M. Hubbard, MD Assistant Professor, Department of Medical Oncology, Mayo Clinic, Rochester, Minnesota
Thomas E. Hughes, PharmD, BCOP Clinical Pharmacy Specialist, Pharmacy Department, Clinical Research Center, National Institutes of Health, Bethesda, Maryland
Geraldine Jacobson, MD, MPH, MBA, FACR Chair, Professor, Department of Radiation Oncology, West Virginia University School of Medicine, WVU Healthcare, Morgantown, West Virginia
Elaine S. Jaffe, MD Chief, Hematopathology Section Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
Abraham S. Kanate, MD Assistant Professor of Medicine, Section of Hematology/Oncology, Marry Babb Randolph Cancer Center, Morgantown, West Virginia
Uzer Khan, MD Academic Chief Resident, Department of Surgery, West Virginia University Hospitals, Morgantown, West Virginia
Hung T. Khong, MD Associate Professor, Division of Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah
Joseph Woong Kim, MD Senior Clinical Fellow, Medical Oncology Service, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
Stephen Ko, MD Instructor, Department of Radiation Oncology, Mayo Clinic Florida, Jacksonville, Florida
David R. Kohler, PharmD Staff Scientist, Clinical Center Pharmacy Department, National Institutes of Health, Bethesda, Maryland
Elise C. Kohn, MD Head, Women’s Cancers Clinic; Head, Molecular Signaling Section; Senior Investigator, Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
Teri Kreisl, MD Staff Clinician, Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
Shaji K. Kumar, MD Professor of Medicine, Consultant, Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota
Jung-min Lee, MD Assistant Clinical Investigator, Women’s Cancers Clinic, Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
Gregory D. Leonard Consultant, University College Hospital Galway, Galway, Ireland
W. Marston Linehan, MD Chief, Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
Ravi A. Madan, MD Assistant Clinical Investigator, Laboratory of Tumor Immunology and Biology, Medical Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
Midhun Malla, MD, MBBS Internal Medicine, St. Joseph Hospital and Medical Center, Phoenix, Arizona
Patrick J. Mansky, MD Medical Oncologist, Medical Director, Clinical Research, The Cancer Team at Bellin Health, Green Bay, Wisconson
Clifton Mo, MD Hematology/Oncology Staff Physician, Department of Medicine, Walter Reed National Military Medical Center, Bethesda, Maryland
Manish Monga, MD Assistant Professor of Medicine, Section of Hematology/Oncology; Medical Director, Clinical Trial Research Unit, Mary Babb Randolph Cancer Center, West Virginia University Hospital, Morgantown, West Virginia
Dominic H. Moon, MD, MBBS National Institutes of Health, Medical Research Scholar Program Fellow, National Institutes of Health, Bethesda, Maryland
Jarushka Naidoo, MB BCH BAO MRCPI Medical Oncology Specialist Registrar, Beaumont Hospital, Connolly Hospital, Royal College of Surgeons, ICORG, Dublin, Ireland
Julie Nangia, MD Assistant Professor, Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas
Anne M. Noonan, MB BCh BAO, MSc, MRCPI Investigator, Medical Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
Maryland Pao, MD Clinical Director, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland
Muzaffar H. Qazilbash, MD Professor of Medicine, Department of Stem Cell Transplantation and Cellular Therapy, Division of Cancer Medicine, The University of Texas M.D. Anderson Cancer Center, Houston, Texas
Sarah Read, MD, MHS Director, Therapeutics Research Program, Division of AIDS, National Institute of Allergy and Infections Diseases, National Institutes of Health, Bethesda, Maryland
Mark Roschewski, MD Staff Clinician, Lymphoma Therapeutics Section, Metabolism Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
Donald L. Rosenstein, MD Professor, Departments of Psychiatry and Medicine; Director, Comprehensive Cancer Support Program, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
Inger Lerra Rosner, MD Director, Urology Oncology; Associate Director, Center for Prostate Disease Research; Assistant Professor of Surgery, USUHS, Walter Reed National Military Medical Center, Bethesda, Maryland
Kerry Ryan, MPH, MS, PA-C Physician Assistant, Medical Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
Yogen Saunthararajah, MD Staff, Hematologic Malignancies and Blood Disorders, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio
Nilay A. Shah, MD Fellow, Section of Hematology/Oncology, Department of Medicine, West Virginia University Hospital, Morgantown, West Virginia
Nishith K. Singh, MD Clinical Fellow, Laboratory of Tumor Immunology and Biology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
Preet Paul Singh, MBBS Fellow in Hematology/Oncology, Mayo Clinic, Rochester, Minnesota
Ramaprasad Srinivasan, MD, PhD Head, Molecular Cancer Section, Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
Lindsay C. Stansfield, PharmD, BCPS Oncology Pharmacy Resident, Pharmacy Department, National Institutes of Health Clinical Center, Bethesda, Maryland
Michael P. Stany, MD Assistant Professor, Uniformed Services University of the Health Sciences, Bethesda, Maryland
Annie Su, MD Fellow, Hematology/Oncology, Baylor College of Medicine, Houston, Texas
Anish Thomas, MBBS, MD Senior Clinical Fellow, Medical Oncology Service, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
Quoc Truong, MD Clinical Assistant Professor of Hematology/Oncology, Cancer Center of Kansas, University of Kansas Medical Center, Wichita, Kansas
Chaitra S. Ujjani, MD Assistant Professor of Medicine, Division of Hematology-Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, DC
Carter Van Waes, MD, PhD Chief, Head and Neck Surgery Branch; Clinical Director, National Institute on Deafness and Other Communication Disorders; Senior Investigator, Radiation Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
Wyndham Wilson, MD, PhD Chief, Lymphoma Therapeutics Section, Metabolism Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
Sarah Zentack, ScM, CGC Instructor, Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas